BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1635 related articles for article (PubMed ID: 18083265)

  • 21. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly(D,L-lactide-co-glycolide).
    Berkland C; Pack DW; Kim KK
    Biomaterials; 2004 Nov; 25(25):5649-58. PubMed ID: 15159081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLGA/mesoporous silica hybrid structure for controlled drug release.
    Xue JM; Shi M
    J Control Release; 2004 Aug; 98(2):209-17. PubMed ID: 15262413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
    Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
    Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
    Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
    Radwan MA; Aboul-Enein HY
    Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone acetate encapsulation into Trojan particles.
    Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
    J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
    Bozdag S; Dillen K; Vandervoort J; Ludwig A
    J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.
    Csaba N; Caamaño P; Sánchez A; Domínguez F; Alonso MJ
    Biomacromolecules; 2005; 6(1):271-8. PubMed ID: 15638530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
    Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
    Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS; Kim CS; Lee KM
    Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
    Gómez-Gaete C; Tsapis N; Besnard M; Bochot A; Fattal E
    Int J Pharm; 2007 Mar; 331(2):153-9. PubMed ID: 17157461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.